Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

Isodiol International Inc.

Isodiol International Inc. offers CBD products.

	Mar '19
net income	-90.28M -
depreciation and amortization	1.54M -
deferred income tax
stock based compensation
change in working capital	-842.47K -
accounts receivables	-4.87M -
inventory	734.16K -
accounts payables	4.27M -
other working capital	-976.41K -
other non cash items	71.59M -
net cash provided by operating activities	-17.99M -
investments in property plant and equipment	-3.35M -
acquisitions net	1.43M -
purchases of investments	-10.25M -
sales maturities of investments	-1 -
other investing activites	-172.36K -
net cash used for investing activites	-12.34M -
debt repayment	-5.91M -
common stock issued	12.57M -
common stock repurchased
dividends paid
other financing activites	11.83M -
net cash used provided by financing activities	18.49M -
effect of forex changes on cash	-0.36 -
net change in cash	-11.76M -
cash at beginning of period	12.06M -
cash at end of period	302.27K -
operating cash flow	-17.99M -
capital expenditure	-3.35M -
free cash flow	-21.34M -

ISOL

COM:ISODIOL

Isodiol International Inc.

Market Cap

135.44K

Beta: -

Volume Today

500

Avg: -

Preview